Intensive Care Units

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MaaT Pharma
MaaT PharmaFrance - Lyon
1 program
1
fecal microbiota transferPhase 21 trial
Active Trials
NCT03350178TerminatedEst. Feb 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MaaT Pharmafecal microbiota transfer

Clinical Trials (1)

NCT03350178MaaT Pharmafecal microbiota transfer

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

Start: Jan 2018Est. completion: Feb 2019
Phase 2Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space